Reactogenicity and immunogenicity of hepatitis A vaccine (Havrix-1440) with the simultaneous administration of Vi polysaccharide typhoid vaccine

Trial Profile

Reactogenicity and immunogenicity of hepatitis A vaccine (Havrix-1440) with the simultaneous administration of Vi polysaccharide typhoid vaccine

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Nov 2010

At a glance

  • Drugs Hepatitis A vaccine inactivated (Primary) ; Typhoid vaccine
  • Indications Hepatitis A; Typhoid
  • Focus Adverse reactions; Pharmacodynamics
  • Most Recent Events

    • 05 Nov 2010 New trial record.
    • 24 Mar 1997 Results published in the Journal of Travel Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top